Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Adverse Events
Biotech
Pliant terminates lung disease trial due to adverse events
Since the discontinuation was announced this morning, Pliant’s stock has halved.
Gabrielle Masson
Mar 3, 2025 11:30am
Cargo offloads CAR-T, 50% of staff over efficacy, side effects
Jan 30, 2025 8:05am
Keros ends hypertension trial over fluid buildups around heart
Jan 15, 2025 8:25am
Keros halts 2 arms of hypertension trial over fluid near heart
Dec 12, 2024 6:30am
Neurogene acts as gene therapy puts person in critical condition
Nov 18, 2024 8:33am
Kronos shelves sole clinical drug over neurological side effects
Nov 14, 2024 5:14am
